Wells, Steven B. https://orcid.org/0000-0001-5428-0683
Rainbow, Daniel B. https://orcid.org/0000-0003-4931-3289
Mark, Michal
Szabo, Peter A. https://orcid.org/0000-0003-1603-761X
Ergen, Can https://orcid.org/0000-0002-3096-2927
Caron, Daniel P. https://orcid.org/0000-0002-1500-8713
Maceiras, Ana Raquel https://orcid.org/0000-0001-7045-1331
Rahmani, Elior
Benuck, Eli
Valiollah Pour Amiri, Valeh https://orcid.org/0000-0002-2008-5297
Chen, David https://orcid.org/0000-0002-9710-1857
Wagner, Allon https://orcid.org/0000-0001-5095-6009
Howlett, Sarah K.
Jarvis, Lorna B. https://orcid.org/0000-0002-5760-0125
Ellis, Karen L.
Kubota, Masaru
Matsumoto, Rei
Mahbubani, Krishnaa https://orcid.org/0000-0002-1327-2334
Saeb-Parsy, Kouresh https://orcid.org/0000-0002-0633-3696
Conde, Cecilia Dominguez
Richardson, Laura https://orcid.org/0000-0002-8075-3816
Xu, Chuan https://orcid.org/0000-0002-6265-999X
Li, Shuang
Mamanova, Lira
Bolt, Liam
Wilk, Alicja
Teichmann, Sarah A. https://orcid.org/0000-0002-6294-6366
Farber, Donna L. https://orcid.org/0000-0001-8236-9183
Sims, Peter A. https://orcid.org/0000-0002-3921-4837
Jones, Joanne L. https://orcid.org/0000-0003-4974-1371
Yosef, Nir https://orcid.org/0000-0001-9004-1225
Article History
Received: 16 December 2024
Accepted: 1 July 2025
First Online: 13 August 2025
Competing interests
: In the past 3 years, J.L.J. has consulted for or been a member of a scientific advisory board for Sanofi, Roche and Enhanc3DGenomics, and S.A.T. S.A.T. is a scientific advisory board member of ForeSite Labs, OMass Therapeutics, Qiagen, Xaira Therapeutics, a co-founder and equity holder of TransitionBio and Ensocell Therapeutics, a non-executive director of 10x Genomics, and a part-time employee of GlaxoSmithKline. The other authors declare no competing interests.